Plasma cell myeloma, also known as multiple myeloma, is a type of cancer that affects plasma cells in the bone marrow. These abnormal plasma cells multiply uncontrollably, crowding out healthy blood cells and weakening bones. Recent research in cancer therapy has shown promising developments in treating plasma cell myeloma. Immunotherapies, such as CAR-T cell therapy, are being investigated to target and destroy cancerous plasma cells more effectively. Additionally, advancements in precision medicine allow for personalized treatment approaches based on a patient's genetic makeup and disease characteristics. Researchers are also exploring novel drug combinations and targeted therapies to improve outcomes and reduce the side effects of treatment. These innovations offer hope for better management and ultimately, a cure for plasma cell myeloma.



Title : Multiplexed biosensor detection of cancer biomarkers
Michael Thompson, University of Toronto, Canada
Title : Nanomedicine in over 45,000 patients and no cancer
Thomas Jay Webster, Brown University, United States